Acelyrin, Inc. (SLRN)

NASDAQ: SLRN · IEX Real-Time Price · USD
6.75
+0.10 (1.50%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Total Valuation

Acelyrin has a market cap or net worth of $657.04 million. The enterprise value is -$130.14 million.

Market Cap 657.04M
Enterprise Value -130.14M

Important Dates

The next estimated earnings date is Tuesday, April 9, 2024, before market open.

Earnings Date Apr 9, 2024
Ex-Dividend Date n/a

Share Statistics

Acelyrin has 97.34 million shares outstanding. The number of shares has increased by 5,390.74% in one year.

Shares Outstanding 97.34M
Shares Change (YoY) +5,390.74%
Shares Change (QoQ) +48.55%
Owned by Insiders (%) 20.59%
Owned by Institutions (%) 91.28%
Float 62.91M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.90
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.89, with a Debt / Equity ratio of 0.00.

Current Ratio 11.89
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$6.00M
Employee Count 51
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 7.66
200-Day Moving Average 13.07
Relative Strength Index (RSI) 38.33
Average Volume (30 Days) 1,263,442

Short Selling Information

The latest short interest is 8.41 million, so 8.64% of the outstanding shares have been sold short.

Short Interest 8.41M
Short Previous Month 6.93M
Short % of Shares Out 8.64%
Short % of Float 13.37%
Short Ratio (days to cover) 6.79

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income -306.24M
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) -$5.06
Full Income Statement

Balance Sheet

The company has $788.43 million in cash and $1.25 million in debt, giving a net cash position of $787.18 million or $8.09 per share.

Cash & Cash Equivalents 788.43M
Total Debt 1.25M
Net Cash 787.18M
Net Cash Per Share $8.09
Equity / Book Value 732.38M
Book Value Per Share 7.52
Working Capital 727.78M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5,390.74%
Shareholder Yield -5,390.74%
Earnings Yield -46.61%
FCF Yield n/a

Analyst Forecast

The average price target for Acelyrin is $24.00, which is 255.56% higher than the current price. The consensus rating is "Buy".

Price Target $24.00
Price Target Difference 255.56%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -45.53%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a